v2.4.0.8
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2014
Equity [Abstract]  
Summary of Option Activity

A summary of option activity under all of the above plans as of September 30, 2014 and changes during the nine months then ended is presented in the table below (shares in thousands):

 

     Shares     Wtd. Avg.
Exercise Price
     Wtd. Avg.
Remaining
Contractual
Life in Years
 

Outstanding at December 31, 2013

     893      $ 0.72      

Granted

     —       $ —       

Exercised

     (174   $ 0.78      

Expired

     (12   $ 3.00      

Forfeited

     (7   $ 0.73      
  

 

 

      

Outstanding at September 30, 2014

     700      $ 0.67         4.21   
  

 

 

      

Vested and expected to vest

     681      $ 0.66         4.15   

Exercisable at September 30, 2014

     535      $ 0.65         3.59   
Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options at September 30, 2014 and changes during the nine months then ended is presented below (shares in thousands):

 

     Shares     Weighted-average
grant-date fair value
 

Non-vested at December 31, 2013

     276      $ 0.58   

Granted

     —       $ —    

Vested

     (104   $ 0.58   

Forfeited

     (7   $ 0.58   
  

 

 

   

 

 

 

Non-vested at September 30, 2014

     165      $ 0.58   
  

 

 

   

 

 

Stock-Based Compensation Included in Unaudited Results of Operations

The Company’s stock-based compensation is classified in the same expense line items as cash compensation. Information about stock-based compensation included in the unaudited results of operations for the three and nine months ended September 30, 2014 and 2013 is as follows (in thousands):

 

     For the Three Months Ended
September 30,
     For the Nine Months Ended
September 30,
 
     2014      2013      2014      2013  

Officer compensation

   $ 9       $ 7       $ 27       $ 38   

Non-employee directors

     4         2         13         11   

Sales, general and administrative

     6         3         20         15   

Research and development

     —          —          —          40   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock option/warrant expense, included in total operating expenses

   $ 19       $ 12       $ 60       $ 104